| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $26,506,886 ) (Continued on the next page) |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01HD114708 | An integrated intervention to address the double burden of maternal child malnutrition in Guatemala | 000 | 2 | NIH | 1/14/2026 | $370,115 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K24AR085342 | Mentoring Patient-Oriented Research Leveraging Bioinformatics to Study CV Risk in Rheumatic Disease | 000 | 2 | NIH | 1/19/2026 | $171,396 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K24HL173667 | Patient oriented research and mentoring in COPD biomarker studies | 000 | 2 | NIH | 1/31/2026 | $131,783 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K24AI180296 | Patient-Oriented Research Mentorship and Training in Upper Airway Allergic and Inflammatory Diseases | 000 | 3 | NIH | 12/10/2025 | $174,031 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K25HL173665 | Methods for Unraveling the Impact of Dietary Xenobiotics on COPD Exacerbations with Multi-Dimensional Networks | 000 | 3 | NIH | 2/6/2026 | $163,485 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K01AG080030 | Living beyond cancer: the short- and long-term cognitive effects of breast cancer and its treatment for cancer survivors | 000 | 4 | NIH | 1/14/2026 | $130,950 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K01DA059572 | Linking Genetic and Clinical Data to Optimize Surgical Opioid Analgesic Prescribing and Predict Risks of Opioid-Related Adverse Drug Events | 000 | 3 | NIH | 1/27/2026 | $198,520 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K00CA284295 | Enhancing Anti-Tumor Immunity against Glioblastoma through Neoantigen-Specific T Cells and Myeloid Checkpoint Blockade | 000 | 3 | NIH | 2/2/2026 | $89,035 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K00CA274651 | Development of Lipid Nanoparticles for B-cell Mediated Immunotherapies | 000 | 4 | NIH | 12/10/2025 | $80,231 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K02NS131521 | Restoring Cortical Network Function in Rett Syndrome | 000 | 3 | NIH | 1/13/2026 | $257,731 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K08ES034822 | Investigating environmental and gene-environment contributors to Parkinson's disease risk by coupling quantitative environmental exposure data to iPSC modeling | 000 | 4 | NIH | 12/31/2025 | $209,607 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K08AR085165 | DISSECTING THE SPATIAL HETEROGENEITY OF SYNOVIAL INFLAMMATION IN RHEUMATOID ARTHRITIS | 000 | 2 | NIH | 1/26/2026 | $170,101 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01HD107726 | Mind the gaps: Pharmacokinetic research to advance pediatric HIV/TB cotreatment and TB prevention | 002 | 4 | NIH | 2/6/2026 | $49,912 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01HD107726 | Mind the gaps: Pharmacokinetic research to advance pediatric HIV/TB cotreatment and TB prevention | 001 | 4 | NIH | 1/30/2026 | $66,240 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01HD107726 | Mind the gaps: Pharmacokinetic research to advance pediatric HIV/TB cotreatment and TB prevention | 000 | 4 | NIH | 1/28/2026 | $190,326 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01ES025530 | Role of AHR in Dendritic Cells in the Control of CNS Autoimmunity | 000 | 10 | NIH | 2/9/2026 | $372,171 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01DK141535 | The role of SRCAP in therapy related clonal hematopoiesis | 000 | 2 | NIH | 12/15/2025 | $508,759 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01EB035091 | Abbreviated yet enhanced neuro MRI protocol | 000 | 2 | NIH | 12/5/2025 | $384,451 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01DK138260 | Development of novel PD1 agonist therapeutic strategies for inflammatory bowel disease | 000 | 3 | NIH | 12/22/2025 | $463,650 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01ES034079 | Geospatially modeled environmental risk factors for lymphoid malignancies | 000 | 3 | NIH | 12/9/2025 | $687,459 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01ES036206 | Per- and polyfluoroalkyl substances, apolipoproteins, and risk of coronary heart disease | 000 | 3 | NIH | 1/23/2026 | $702,689 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01CA295752 | DNA damage-related stemness program during BRCA1 breast cancer initiation | 000 | 2 | NIH | 12/31/2025 | $477,805 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01CA295683 | Development and optimization of highly effective treatments in patients with head and neck cancer using in situ implantable microdevices | 000 | 2 | NIH | 2/2/2026 | $597,637 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01CA288535 | Cell surface receptor targeted therapies for brain tumors | 000 | 2 | NIH | 12/18/2025 | $370,543 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01AR080194 | New approaches to safety monitoring of novel systemic treatments for atopic dermatitis in clinical practice and underrepresented populations | 000 | 5 | NIH | 1/8/2026 | $570,768 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01AR080659 | Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases | 000 | 4 | NIH | 2/2/2026 | $668,445 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01CA267479 | MicroRNA control of tumor-promoting inflammation in colon cancer | 000 | 5 | NIH | 2/12/2026 | $347,698 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01AG074899 | Autophagon: an Autophagy-Functionalizing Gene Therapy Tool for Neurodegenerative Diseases | 000 | 6 | NIH | 1/13/2026 | $672,524 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01AI144166 | Role of Tim-3:Bat-3 pathway in inducing tolerogenic DCs and peripheral tolerance | 000 | 7 | NIH | 12/29/2025 | $512,496 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01AG082346 | Mechanisms of Somatic Mutation in Alzheimer's Disease Using Single Neuron Analysis | 000 | 3 | NIH | 12/11/2025 | $804,192 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01AG084531 | Combination Therapy with Semaglutide and Anti-Amyloid Antibodies for Alzheimers Disease | 000 | 3 | NIH | 1/23/2026 | $756,649 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01AG080429 | Leveraging Longitudinal Data and Informatics Technology to Understand the Role of Bilingualism in Cognitive Resilience, Aging and Dementia | 000 | 4 | NIH | 1/30/2026 | $1,197,516 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01AI179807 | Harnessing commensal redox metabolism in infection prevention | 000 | 3 | NIH | 12/4/2025 | $849,858 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K08NS136723 | Immune Regulation of the Blood-Brain Barrier | 000 | 2 | NIH | 12/17/2025 | $230,580 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K23DK125672 | Novel Pathways and Therapeutic Targets for Cisplatin-Associated Acute Kidney Injury | 000 | 5 | NIH | 12/19/2025 | $188,266 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K23AR080203 | Multi-omic Studies of Local and Systemic Immune Dysregulation in Rosacea | 000 | 5 | NIH | 1/7/2026 | $169,884 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K25HL157601 | Structural and Funcional Vascular Phenotyping in Smokers with Pulmonary Hypertension using Artificial Intelligence | 000 | 3 | NIH | 2/12/2026 | $189,000 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R38AG085422 | Mentored Research Training in Aging and Surgery (MERITAS) | 000 | 3 | NIH | 1/22/2026 | $403,611 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R35GM153468 | Decoding the Molecular Mechanisms Governing Regulation and Reprogramming of Cellular Identity | 000 | 3 | NIH | 1/27/2026 | $403,650 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R21HD117308 | Continuous Non-Invasive Blood Pressure Monitoring in Neonates using Wearable Wireless NIRS | 000 | 2 | NIH | 12/12/2025 | $234,746 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01MH136503 | Using Neuroimaging to Investigate Mechanism-based Biomarkers of Schizophrenia | 001 | 2 | NIH | 1/9/2026 | $272,636 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01MH136503 | Using Neuroimaging to Investigate Mechanism-based Biomarkers of Schizophrenia | 000 | 2 | NIH | 1/8/2026 | $349,669 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01MH136160 | Precision TMS with integrated visualization and analysis of real-time E-field and EEG source imaging | 000 | 2 | NIH | 1/23/2026 | $751,514 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01NS131182 | Chemogenetic Neurovascular Oxidative Stress: Neurodegeneration and Cardiac Remodeling | 000 | 3 | NIH | 1/19/2026 | $539,650 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01NS131182 | Chemogenetic Neurovascular Oxidative Stress: Neurodegeneration and Cardiac Remodeling | 000 | 3 | NIH | 1/19/2026 | $159,177 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01NS136297 | Optimizing Neuromodulation Therapies for Epilepsy: Identifying the Right Patient, Right Place, and Right Time for Stimulation | 000 | 2 | NIH | 12/12/2025 | $590,408 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R01NS119476 | Next Generation Gene Therapy for Refractory Pain | 000 | 5 | NIH | 2/9/2026 | $633,664 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R03CA295675 | Mixed Lineage Kinase 2 (MLK2) in tumor angiogenesis | 000 | 2 | NIH | 1/13/2026 | $74,862 |
| | 2026 | 2026 | BRIGHAM & WOMENS HOSPITAL INC | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | R03DE034380 | Medicaid coverage of treatment for periodontal disease and its impact on health outcomes | 000 | 2 | NIH | 1/20/2026 | $167,327 |
|
